Results 61 to 70 of about 89 (85)
Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
Metabolism Open, 2021 The recognition of the rare but serious and potentially lethal complication of vaccine induced thrombotic thrombocytopenia (VITT) raised concerns regarding the safety of COVID-19 vaccines and led to the reconsideration of vaccination strategies in many countries. Following the description of VITT among recipients of adenoviral vector ChAdOx1 vaccine, a
Irene Karampela, Dimitrios Tsilingiris
exaly +5 more sources
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia
New England Journal of Medicine, 2021 The use of high-dose intravenous immune globulin (IVIG) plus anticoagulation is recommended for the treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT), a rare side effect of adenoviral vector vaccines against coronavirus disease 2019 (Covid-19). We describe the response to IVIG therapy in three of the first patients in whom VITT was
Ishac Nazy +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Thrombosis and Hemostasis, 2023
AbstractHeparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high rates of thrombosis-related morbidity and mortality. HIT is a long-recognized reaction to the administration of the common parenterally administered anticoagulant heparin (or its ...
Maria V, Selvadurai +2 more
openaire +2 more sources
AbstractHeparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic thrombocytopenia (VITT) are rare, iatrogenic immune-mediated conditions with high rates of thrombosis-related morbidity and mortality. HIT is a long-recognized reaction to the administration of the common parenterally administered anticoagulant heparin (or its ...
Maria V, Selvadurai +2 more
openaire +2 more sources
AbstractIn late February 2021, a prothrombotic syndrome was encountered for the first time in some of the recipients of ChAdOx1 CoV‐19 vaccine (AstraZeneca, University of Oxford, and Serum Institute of India). Since the hallmark of this syndrome is the development of thrombocytopenia and/or thrombosis between 4 and 42 days after receiving a COVID‐19 ...
Fazal‐i‐Akbar Danish +4 more
openaire +2 more sources
2023
Heparin-induced thrombocytopenia (HIT) represents an autoimmune process whereby antibodies are formed against heparin in complex with platelet factor 4 (PF4) after heparin administration. These antibodies can be detected by a variety of immunological assays, including ELISA (enzyme-linked immunosorbent assay) and by chemiluminescence on the AcuStar ...
Emmanuel J. Favaloro, Leonardo Pasalic
openaire +2 more sources
Heparin-induced thrombocytopenia (HIT) represents an autoimmune process whereby antibodies are formed against heparin in complex with platelet factor 4 (PF4) after heparin administration. These antibodies can be detected by a variety of immunological assays, including ELISA (enzyme-linked immunosorbent assay) and by chemiluminescence on the AcuStar ...
Emmanuel J. Favaloro, Leonardo Pasalic
openaire +2 more sources
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
Thrombosis and Haemostasis, 2021A series of cases with rare thromboembolic incidents including cerebral sinus vein thrombosis (some of them fatal) and concomitant thrombocytopenia occurring shortly after vaccination with the coronavirus disease 2019 (COVID-19) vaccine AZD1222 (Vaxzevria) have caused significant concern and led to its temporary suspension in many countries.
von Hundelshausen, Philipp +3 more
openaire +1 more source
Vaccine-induced thrombotic thrombocytopenia following coronavirus vaccine: A narrative review
Annals of Medicine and Surgery, 2022Summaiyya Waseem +2 more
exaly
Laboratory testing for suspected COVID-19 vaccine–induced (immune) thrombotic thrombocytopenia
International Journal of Laboratory Hematology, 2021exaly